全文获取类型
收费全文 | 1382738篇 |
免费 | 97169篇 |
国内免费 | 3071篇 |
专业分类
耳鼻咽喉 | 20249篇 |
儿科学 | 41169篇 |
妇产科学 | 39340篇 |
基础医学 | 193259篇 |
口腔科学 | 40462篇 |
临床医学 | 117018篇 |
内科学 | 273463篇 |
皮肤病学 | 30690篇 |
神经病学 | 110888篇 |
特种医学 | 55534篇 |
外国民族医学 | 435篇 |
外科学 | 215617篇 |
综合类 | 31569篇 |
现状与发展 | 6篇 |
一般理论 | 497篇 |
预防医学 | 95361篇 |
眼科学 | 32098篇 |
药学 | 102916篇 |
4篇 | |
中国医学 | 3028篇 |
肿瘤学 | 79375篇 |
出版年
2018年 | 13193篇 |
2016年 | 11619篇 |
2015年 | 13139篇 |
2014年 | 18532篇 |
2013年 | 27440篇 |
2012年 | 36720篇 |
2011年 | 38578篇 |
2010年 | 22855篇 |
2009年 | 22133篇 |
2008年 | 36876篇 |
2007年 | 40054篇 |
2006年 | 40527篇 |
2005年 | 39264篇 |
2004年 | 38014篇 |
2003年 | 36768篇 |
2002年 | 36001篇 |
2001年 | 63899篇 |
2000年 | 65522篇 |
1999年 | 55671篇 |
1998年 | 15077篇 |
1997年 | 13847篇 |
1996年 | 13259篇 |
1995年 | 12509篇 |
1994年 | 11694篇 |
1992年 | 42888篇 |
1991年 | 41393篇 |
1990年 | 40659篇 |
1989年 | 39634篇 |
1988年 | 37036篇 |
1987年 | 36472篇 |
1986年 | 34970篇 |
1985年 | 33193篇 |
1984年 | 24927篇 |
1983年 | 21147篇 |
1982年 | 12783篇 |
1981年 | 11666篇 |
1979年 | 23961篇 |
1978年 | 17123篇 |
1977年 | 14887篇 |
1976年 | 13432篇 |
1975年 | 15307篇 |
1974年 | 18116篇 |
1973年 | 17592篇 |
1972年 | 16823篇 |
1971年 | 15732篇 |
1970年 | 14931篇 |
1969年 | 14358篇 |
1968年 | 13478篇 |
1967年 | 12021篇 |
1966年 | 11265篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
1.
2.
3.
Aaron Pitzele Mohammad Rahimi Eric Armbrecht 《The journal of maternal-fetal & neonatal medicine》2015,28(15):1770-1773
Objective: To determine whether packed red blood cell (PRBC) transfusion affects post-prandial superior mesenteric artery blood flow velocities (SMA BFVs) in very-low birth weight (VLBW) neonates and if so, at what time point after transfusion restoration of previous SMA BFV patterns occurs.Design/Methods: VLBW pre-term neonates, older than 14 days and tolerating bolus enteral feedings administered every 3?h were enrolled in this prospective observational study. Pulsed Doppler ultrasound was used to measure pre- and post-prandial (at 45?min) time-averaged mean, peak and end diastolic velocities (TAMV, PSV, EDV) immediately before and after 15?ml/kg of PRBC transfusion was given over 3?h; patent ductus arteriosus (PDA) status was also evaluated. Subsequent pre- and post-prandial SMA BFVs were recorded 24 and 48?h after the transfusion.Results: Pre- and post-prandial measurements were obtained for 21 out of 25 enrolled infants. Post-prandial SMA BFVs were attenuated during the feedings immediately after transfusion; at 24 and 48?h after transfusion, changes in post-prandial SMA BFVs were similar to those measured prior to transfusion; the presence of the PDA did not affect results.Conclusions: PRBC transfusion blunted SMA BFV responses to feedings immediately after the transfusion with normalization observed 24?h post-transfusion. 相似文献
4.
Improvement in Tricuspid Annular Plane Systolic Excursion with Pulmonary Hypertension Therapy in Pediatric Patients 下载免费PDF全文
5.
6.
7.
8.
9.
10.
E. Niclas Jonsson Rujia Xie Scott F. Marshall Rosalin H. Arends 《British journal of clinical pharmacology》2016,81(4):688-699
AimsThe aims were to 1) develop the pharmacokinetics model to describe and predict observed tanezumab concentrations over time, 2) test possible covariate parameter relationships that could influence clearance and distribution and 3) assess the impact of fixed dosing vs. a dosing regimen adjusted by body weight.MethodsIndividual concentration–time data were determined from 1608 patients in four phase 3 studies conducted to assess efficacy and safety of intravenous tanezumab. Patients received two or three intravenous doses (2.5, 5 or 10 mg) every 8 weeks. Blood samples for assessment of tanezumab PK were collected at baseline, 1 h post‐dose and at weeks 4, 8, 16 and 24 (or early termination) in all studies. Blood samples were collected at week 32 in two studies. Plasma samples were analyzed using a sensitive, specific, validated enzyme‐linked immunosorbent assay.ResultsA two compartment model with parallel linear and non‐linear elimination processes adequately described the data. Population estimates for clearance (CL), central volume (V
1), peripheral volume (V
2), inter‐compartmental clearance, maximum elimination capacity (VM) and concentration at half‐maximum elimination capacity were 0.135 l day–1, 2.71 l, 1.98 l, 0.371 l day–1, 8.03 μg day–1 and 27.7 ng ml–1, respectively. Inter‐individual variability (IIV) was included on CL, V
1, V
2 and VM. A mixture model accounted for the distribution of residual error. While gender, dose and creatinine clearance were significant covariates, only body weight as a covariate of CL, V
1 and V
2 significantly reduced IIV.ConclusionsThe small increase in variability associated with fixed dosing is consistent with other monoclonal antibodies and does not change risk : benefit. 相似文献